Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ: INBS )

1.500 +0.090 (+6.38%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,284
Open 1.420
Bid (Size) 1.520 (1)
Ask (Size) 1.560 (2)
Prev. Close 1.410
Today's Range 1.415 - 1.500
52wk Range 1.302 - 31.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
Via AB Newswire
Exposures Product Safety
“Intelligent Bio Solutions (Nasdaq: INBS) Expands Influence with Key Client Accounts in UK Manufacturing Sector”
Via AB Newswire

Performance

YTD
-62.10%
-62.10%
1 Month
-15.25%
-15.25%
3 Month
-44.24%
-44.24%
6 Month
-42.92%
-42.92%
1 Year
-94.73%
-94.73%

More News

Read More
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Revolutionizes Drug Testing Ensuring Workplace Safety; Poised for Global Expansion
Via AB Newswire
Topics Cannabis
Exposures Cannabis
July 2024 Hot Small-Cap Stocks Under $5 Gaining Now: KAVL, VTAK, INBS, BSFC, PRSO
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Via AB Newswire
Topics Economy
Exposures Product Safety Supply Chain
Looking Into Intelligent Bio Solutions's Recent Short Interest
Via Benzinga
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
Via AB Newswire
Exposures Product Safety
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
Via AB Newswire
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Research Report Update May 2024
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!
Via AB Newswire
Market Movers on The Street: LAZR, INBS, REBN, PSRO
Via AB Newswire
INBS Stock Earnings: Intelligent Bio Solutions Beats EPS, Misses Revenue for Q3 2024
Via InvestorPlace
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Pioneering Advances in Medical Technology – Full Analysis Inside!
Via AB Newswire
Exposures Product Safety
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII
Via AB Newswire
Topics Government
Exposures Political
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
Via AB Newswire
Topics Initial Public Offering
Exposures Product Safety Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.